Patent ID: 11938302
Assignee: EOFLOW CO., LTD.
Field: Medical technology (Instruments)
Classification: CPC A  G | IPC A  G

Claim 4:
5. An insulin patch control device comprising
a processor,
wherein the processor is configured to:
obtain blood sugar information measured by a blood sugar sensor, input the obtained blood sugar information to a first neural network, estimate pump parameters of the insulin patch based on output data of the first neural network, and simulate the insulin patch by selecting one of the estimated pump parameters, wherein
in a case where an expected blood sugar level exceeds an effective range as a result of simulation, it is determined that the estimated pump parameter is not effective, and another pump parameter is selected from among the estimated pump parameters or a pump parameter is re-estimated, and
in a case when an expected blood sugar level is within an effective range as a result of simulation, a control signal is transmitted to the insulin patch, a control result of the insulin patch is obtained from the insulin patch, and the obtained blood sugar information and the estimated pump parameters are transmitted to a second neural network to obtain first pathology diagnosis result data, and then, by using a control result of the insulin patch, feedback is performed to the second neutral network in relation to the first pathology diagnosis result data.